CanMED: NDC

Drug Name (Brand or Generic) Separate terms with OR to return results that match either term.

Major Class

Package in use from (mm/dd/yyyy):

To:

SEER*Rx Category

Clear All

10,000 Matching Results — Export these results

Click column titles once to sort ascending, and twice to sort descending.

Show Entries

NDC-11 (Package)	NDC-9 (Product)	Generic Name	Brand Name	Strength	SEER*Rx Category	Major Class	Minor Class	Administration Route	Package Effective Date	Status
55513-0004-01	55513-0004	Darbepoetin alfa	Aranesp	60.0 ug/mL	Ancillary Therapy	Erythropoiesis-Stimulating Agent		Intravenous, Subcutaneous	Sept. 11, 2006	In Use
55513-0004-04	55513-0004	Darbepoetin alfa	Aranesp	60.0 ug/mL	Ancillary Therapy	Erythropoiesis-Stimulating Agent		Intravenous, Subcutaneous	Sept. 11, 2006	In Use
55513-0021-01	55513-0021	Darbepoetin alfa	Aranesp	40.0 ug/.4mL	Ancillary Therapy	Erythropoiesis-Stimulating Agent		Intravenous, Subcutaneous	Feb. 18, 2011	In Use
55513-0021-04	55513-0021	Darbepoetin alfa	Aranesp	40.0 ug/.4mL	Ancillary Therapy	Erythropoiesis-Stimulating Agent		Intravenous, Subcutaneous	Aug. 14, 2006	In Use
00904-6551-61	00904-6551	Ondansetron hydrochloride	Ondansetron hydrochloride	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Dec. 26, 2006	In Use
00904-6552-61	00904-6552	ondansetron hydrochloride	ondansetron hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Dec. 26, 2006	In Use
23155-0549-31	23155-0549	Ondansetron	Ondansetron	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intramuscular, Intravenous	June 15, 2012	In Use
23155-0550-31	23155-0550	Ondansetron	Ondansetron	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intramuscular, Intravenous	Nov. 9, 2015	In Use
25021-0777-02	25021-0777	ondansetron hydrochloride	Ondansetron	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intramuscular, Intravenous	Aug. 30, 2012	In Use
43063-0273-04	43063-0273	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Jan. 27, 2011	In Use
43063-0770-06	43063-0770	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	March 3, 2014	In Use
43063-0792-06	43063-0792	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Oct. 6, 2017	In Use
50090-1201-00	50090-1201	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Nov. 28, 2014	In Use
51672-4091-03	51672-4091	ondansetron hydrochloride	Ondansetron	4.0 mg/5mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Nov. 30, 2007	In Use
55150-0125-02	55150-0125	Ondansetron Hydrochloride	Ondansetron	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intramuscular, Intravenous	Dec. 21, 2012	In Use
55150-0126-20	55150-0126	Ondansetron Hydrochloride	Ondansetron	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intramuscular, Intravenous	Dec. 21, 2012	In Use
55154-2876-05	55154-2876	Ondansetron	Ondansetron	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intramuscular, Intravenous	Dec. 26, 2006	In Use
55154-2877-05	55154-2877	Ondansetron	Ondansetron	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intramuscular, Intravenous	Dec. 26, 2006	In Use
55154-4567-00	55154-4567	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 2, 2007	In Use
55700-0672-10	55700-0672	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 24, 2018	In Use
55700-0672-65	55700-0672	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Sept. 14, 2018	In Use
60505-6130-00	60505-6130	Ondansetron	Ondansetron	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intramuscular, Intravenous	May 26, 2016	In Use
60505-6130-05	60505-6130	Ondansetron	Ondansetron	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intramuscular, Intravenous	May 26, 2016	In Use
60760-0637-10	60760-0637	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 31, 2007	In Use
60760-0637-15	60760-0637	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 3, 2020	In Use
60760-0637-30	60760-0637	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Oct. 10, 2019	In Use
63187-0002-10	63187-0002	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Nov. 1, 2018	In Use
63187-0002-15	63187-0002	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Nov. 1, 2018	In Use
63187-0002-20	63187-0002	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Nov. 1, 2018	In Use
63187-0002-30	63187-0002	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Nov. 1, 2018	In Use
63187-0065-10	63187-0065	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 1, 2014	In Use
63187-0065-15	63187-0065	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 1, 2014	In Use
63187-0065-20	63187-0065	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 1, 2014	In Use
63187-0065-30	63187-0065	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 1, 2014	In Use
63187-0065-60	63187-0065	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 1, 2014	In Use
63187-0065-90	63187-0065	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 1, 2014	In Use
63187-0236-10	63187-0236	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 1, 2014	In Use
63187-0236-15	63187-0236	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 1, 2014	In Use
63187-0236-20	63187-0236	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 1, 2014	In Use
63187-0483-10	63187-0483	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Nov. 1, 2018	In Use
63187-0483-15	63187-0483	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Nov. 1, 2018	In Use
63187-0483-20	63187-0483	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Nov. 1, 2018	In Use
55513-0023-01	55513-0023	Darbepoetin alfa	Aranesp	60.0 ug/.3mL	Ancillary Therapy	Erythropoiesis-Stimulating Agent		Intravenous, Subcutaneous	Feb. 18, 2011	In Use
55513-0023-04	55513-0023	Darbepoetin alfa	Aranesp	60.0 ug/.3mL	Ancillary Therapy	Erythropoiesis-Stimulating Agent		Intravenous, Subcutaneous	Aug. 14, 2006	In Use
63304-0458-30	63304-0458	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 25, 2007	In Use
63304-0459-30	63304-0459	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 25, 2007	In Use
63323-0373-02	63323-0373	ONDANSETRON HYDROCHLORIDE	Ondansetron	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intramuscular, Intravenous	Nov. 18, 2009	In Use
63323-0374-20	63323-0374	ONDANSETRON HYDROCHLORIDE	Ondansetron	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intramuscular, Intravenous	Nov. 18, 2009	In Use
63629-4093-00	63629-4093	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 27, 2010	In Use
63629-4093-01	63629-4093	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 3, 2009	In Use
63629-4093-02	63629-4093	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 3, 2009	In Use
63629-4093-03	63629-4093	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 3, 2009	In Use
63629-4093-04	63629-4093	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 3, 2009	In Use
63629-4093-05	63629-4093	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 3, 2009	In Use
63629-4093-06	63629-4093	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 3, 2009	In Use
63629-4093-07	63629-4093	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 27, 2010	In Use
63629-4093-08	63629-4093	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 27, 2010	In Use
63629-4093-09	63629-4093	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 27, 2010	In Use
63629-4306-00	63629-4306	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 20, 2010	In Use
63629-4306-01	63629-4306	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 19, 2013	In Use
63629-4306-02	63629-4306	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 19, 2013	In Use
63629-4306-03	63629-4306	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 19, 2013	In Use
63629-4306-04	63629-4306	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 20, 2010	In Use
63629-4306-05	63629-4306	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 20, 2010	In Use
63629-4306-06	63629-4306	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 20, 2010	In Use
63629-4306-07	63629-4306	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 20, 2010	In Use
63629-4306-08	63629-4306	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 20, 2010	In Use
63629-4306-09	63629-4306	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 20, 2010	In Use
65862-0187-03	65862-0187	Ondansetron Hydrochloride	Ondansetron Hydrochloride	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 31, 2007	In Use
65862-0187-05	65862-0187	Ondansetron Hydrochloride	Ondansetron Hydrochloride	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 31, 2007	In Use
65862-0187-10	65862-0187	Ondansetron Hydrochloride	Ondansetron Hydrochloride	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 31, 2007	In Use
65862-0187-30	65862-0187	Ondansetron Hydrochloride	Ondansetron Hydrochloride	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 31, 2007	In Use
65862-0187-99	65862-0187	Ondansetron Hydrochloride	Ondansetron Hydrochloride	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 31, 2007	In Use
65862-0188-03	65862-0188	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 31, 2007	In Use
65862-0188-05	65862-0188	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 31, 2007	In Use
65862-0188-10	65862-0188	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 31, 2007	In Use
65862-0188-30	65862-0188	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 31, 2007	In Use
65862-0188-99	65862-0188	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 31, 2007	In Use
65862-0189-11	65862-0189	Ondansetron Hydrochloride	Ondansetron Hydrochloride	24.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 31, 2007	In Use
65862-0208-04	65862-0208	Ondansetron Hydrochloride	Ondansetron	4.0 mg/5mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Nov. 28, 2007	In Use
65862-0208-50	65862-0208	Ondansetron Hydrochloride	Ondansetron	4.0 mg/5mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Nov. 28, 2007	In Use
80175-0017-01	80175-0017	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 11, 2018	In Use
80175-0017-03	80175-0017	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 11, 2018	In Use
80175-0017-05	80175-0017	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 11, 2018	In Use
80175-0017-06	80175-0017	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 11, 2018	In Use
67184-0507-01	67184-0507	Ondansetron	Ondansetron	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intramuscular, Intravenous	Sept. 8, 2014	In Use
67184-0507-05	67184-0507	Ondansetron	Ondansetron	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intramuscular, Intravenous	Sept. 8, 2014	In Use
68083-0113-01	68083-0113	Ondansetron	Ondansetron	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intramuscular, Intravenous	Sept. 25, 2009	In Use
68083-0114-01	68083-0114	Ondansetron	Ondansetron	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intramuscular, Intravenous	June 15, 2012	In Use
68462-0105-30	68462-0105	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 25, 2007	In Use
68462-0105-33	68462-0105	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 25, 2007	In Use
68462-0106-30	68462-0106	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 25, 2007	In Use
68462-0106-33	68462-0106	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 25, 2007	In Use
76045-0103-20	76045-0103	ONDANSETRON HYDROCHLORIDE	Ondansetron	4.0 mg/2mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intramuscular, Intravenous	Dec. 10, 2015	In Use
77651-1112-01	77651-1112	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 19, 2020	In Use
67184-0540-01	67184-0540	Fosaprepitant dimeglumine	FOSAPREPITANT DIMEGLUMINE	150.0 mg/5mL	Ancillary Therapy	Antiemetic	Substance P/Neurokinin 1	Intravenous	Sept. 8, 2020	In Use
44206-0456-21	44206-0456	HUMAN IMMUNOGLOBULIN G	Hizentra	0.2 g/mL	Ancillary Therapy	Immunostimulant	Human Immunoglobulin G	Subcutaneous	Jan. 1, 2020	In Use
44206-0456-94	44206-0456	HUMAN IMMUNOGLOBULIN G	Hizentra	0.2 g/mL	Ancillary Therapy	Immunostimulant	Human Immunoglobulin G	Subcutaneous	Jan. 1, 2020	In Use
44206-0457-22	44206-0457	Human Immunoglobulin G	Hizentra	0.2 g/mL	Ancillary Therapy	Immunostimulant	Human Immunoglobulin G	Subcutaneous	Jan. 1, 2020	In Use
44206-0457-95	44206-0457	Human Immunoglobulin G	Hizentra	0.2 g/mL	Ancillary Therapy	Immunostimulant	Human Immunoglobulin G	Subcutaneous	Jan. 1, 2020	In Use

Found 10,000 results in 8 milliseconds — Export these results

CanMED and the Oncology Toolbox

CanMED: NDC